James B Bucher - Net Worth and Insider Trading
James B Bucher Net Worth
The estimated net worth of James B Bucher is at least $185,194 dollars as of 2024-09-20. James B Bucher is the EVP & General Counsel of Alder BioPharmaceuticals Inc and owns about 9,809 shares of Alder BioPharmaceuticals Inc (ALDR) stock worth over $185,194. Details can be seen in James B Bucher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James B Bucher has not made any transactions after 2019-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James B Bucher
James B Bucher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James B Bucher owns 1 companies in total, including Eliem Therapeutics Inc (ELYM) .
Click here to see the complete history of James B Bucher’s form 4 insider trades.
Insider Ownership Summary of James B Bucher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELYM | Eliem Therapeutics Inc | 2021-08-09 | EVP and General Counsel |
James B Bucher Latest Holdings Summary
James B Bucher currently owns a total of 1 stock. James B Bucher owns 9,809 shares of Alder BioPharmaceuticals Inc (ALDR) as of April 25, 2019, with a value of $185,194.
Latest Holdings of James B Bucher
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDR | Alder BioPharmaceuticals Inc | 2019-04-25 | 9,809 | 18.88 | 185,194 |
Holding Weightings of James B Bucher
James B Bucher Form 4 Trading Tracker
According to the SEC Form 4 filings, James B Bucher has made a total of 0 transactions in Alder BioPharmaceuticals Inc (ALDR) over the past 5 years. The most-recent trade in Alder BioPharmaceuticals Inc is the sale of 1,897 shares on April 25, 2019, which brought James B Bucher around $26,274.
Insider Trading History of James B Bucher
- 1
James B Bucher Trading Performance
James B Bucher Ownership Network
James B Bucher Owned Company Details
What does Eliem Therapeutics Inc do?
Who are the key executives at Eliem Therapeutics Inc?
James B Bucher is the EVP and General Counsel of Eliem Therapeutics Inc. Other key executives at Eliem Therapeutics Inc include Chief Scientific Officer Valerie Morisset , director & 10 percent owner Ra Capital Healthcare Fund Lp , and Chief Accounting Officer Emily Pimblett .
Eliem Therapeutics Inc (ELYM) Insider Trades Summary
Over the past 18 months, James B Bucher made no insider transaction in Eliem Therapeutics Inc (ELYM). Other recent insider transactions involving Eliem Therapeutics Inc (ELYM) include a net sale of 481,639 shares made by Valerie Morisset , a net purchase of 13,008,546 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 1,245 shares made by Emily Pimblett .
In summary, during the past 3 months, insiders sold 481,639 shares of Eliem Therapeutics Inc (ELYM) in total and bought 13,008,546 shares, with a net purchase of 12,526,907 shares. During the past 18 months, 482,884 shares of Eliem Therapeutics Inc (ELYM) were sold and 13,008,546 shares were bought by its insiders, resulting in a net purchase of 12,525,662 shares.
Eliem Therapeutics Inc (ELYM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eliem Therapeutics Inc Insider Transactions
James B Bucher Mailing Address
Above is the net worth, insider trading, and ownership report for James B Bucher. You might contact James B Bucher via mailing address: 11804 North Creek Parkway S, Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
